These success, together with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 help the principle of targeting ACKR3 as a novel way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar disorders. Morphine and various opioids enhance the https://charlese121nal7.elbloglibre.com/profile